SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as the community discusses its potential to disrupt the cloud computing industry and integrate AI, with some drawing comparisons to ZCash's previous run. Bullish sentiment is fueled by recent news around the Caffeine AI platform and increased developer activity, as well as speculation about potential partnerships and exchange listings. Community members highlight ICP's unique technology and its potential to offer a decentralized alternative to traditional cloud providers like AWS and Azure.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is trending as community members discuss its potential within the decentralized storage sector and its competition with Amazon AWS. Speculation around AI and data infrastructure projects utilizing Filecoin's network is fueling interest, with some eyeing a return to all-time highs. Technical analysis and discussions of potential breakouts are also prominent.

Ethereum Classic

Ethereum Classic is trending as traders discuss its potential for a significant price increase, drawing comparisons to past bull runs and anticipating a move to catch up with Ethereum's recent gains. Community members are debating entry points and potential price targets, with some highlighting its proof-of-work mechanism and perceived undervaluation as bullish factors. The conversation also includes speculation about broader altcoin season dynamics and the potential impact of upcoming economic events.

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Metsera Inc

MTSR is trending due to ongoing speculation around a potential buyout offer from pharmaceutical giants like $PFE and $NVO, driving community discussion about competing bids and the future of its obesity drug pipeline. The community is actively debating the potential value of MTSR's assets, with some believing the bidding war is far from over, while others suggest that potential regulatory hurdles or superior alternatives may shift focus elsewhere. Broader sector trends in weight-loss and metabolic disease treatments add further context.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending as the community discusses its potential as an ecosystem play, drawing parallels to Ethereum's early stages and highlighting the recent launch of JANCTION within the Jasmy ecosystem. Some investors believe the project is undervalued, while others express concerns about its long-term performance and criticize its price action relative to Bitcoin's movements. Discussions also include potential partnerships and the impact of macroeconomic factors.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings ($ONDS) is trending due to its acquisition of Sentrycs, a counter-drone technology firm, sparking discussions about its potential in the defense sector. The community is focused on how this acquisition will impact Ondas' future contracts and revenue, especially given the increasing need for counter-UAS solutions globally. Bullish sentiment is fueled by the anticipation of strong earnings and the company's strategic positioning in the growing drone and counter-drone market.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as investors discuss its potential as a meme stock with a possible short squeeze, highlighting its low float and upcoming pension transfer. The community is also focused on Kodak's diversification into batteries and pharmaceuticals, and some are anticipating news or partnerships that could drive the stock higher. Despite mixed sentiment, many are optimistic about the company's long-term growth potential.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential buyout, fueled by bidding wars for competitors in the obesity drug space and renewed discussions around pipeline value. Community talking points revolve around the potential price tag Viking could command and speculation around potential acquirers like BMY. Some traders express frustration with the stock's price action, while others remain optimistic about its long-term prospects.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending as investors anticipate upcoming data presentations, particularly CTX310 at the American Heart Association meeting in November, which some believe could be a major catalyst. Bullish sentiment is fueled by insider buying and a growing consensus that the company is undervalued, with the potential for a significant short squeeze. Community members are closely watching for earnings and pipeline updates, while also speculating on potential acquisitions or partnerships.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai (FET) is trending amid discussions about its potential, partnerships, and the broader AI narrative in crypto, with some traders pointing to a possible breakout. Community members are weighing bullish prospects against concerns about its performance relative to other cryptocurrencies and speculating on potential catalysts. The conversation includes price predictions, comparisons to other AI coins, and mentions of upcoming news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medtronic (MDT) Q1 Earnings and Revenues Top Estimates

Medtronic (MDT) delivered earnings and revenue surprises of +2.44% and +2.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of +3.39% and +4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates

Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +26.83% and +51.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

President Donald Trump confirmed on Monday that he is looking at reclassifying marijuana and may announce his final decision in the next few weeks. "We're looking at reclassification, and we'll make a determination over the next few weeks," Trump told reporters during a press conference about cracking down on crime in Washington, D.C.His comments come after The Wall Street Journal (WSJ)&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/politics/policy/trump-marijuana-federal-drug-classification-01a73b8c">reported</a> last week that Trump may be interested in changing the drug’s classification. Marijuana-linked stocks like Aurora Cannabis (ACB), Canopy Growth (CGC), Tilray Brands (TLRY), Cronos Group (CRON), and Trulieve Cannabis (TCNNF) were already rallying in pre-market trade on the report.&nbsp;They continued to rally after Trump’s confirmation, with&nbsp;<a href="http://stocktwits.com/symbol/CGC">Canopy Growth’s</a> stock surging nearly 30% in midday trade.&nbsp;<a href="http://stocktwits.com/symbol/TLRY">Tilray’s stock</a> jumped 22%, followed by&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="http://tcnnf">Trulieve’s stock</a> gaining more than 18%. Aurora Cannabis’s stock climbed 12.5% on Monday.On Stocktwits, retail sentiment around Canopy Growth moved higher within ‘extremely bullish’ territory amid ‘extremely high’ levels of chatter. Meanwhile, retail sentiment around Tilray Brands improved to ‘bullish’ from ‘bearish’ a day ago, and retail sentiment around Trulieve was moved higher within ‘extremely bullish’ territory.“Some people like it. Some people hate it. Some people hate the whole concept of marijuana, because if it’s bad for the children, it’s bad for people older than children,” the President said, noting that medical marijuana, specifically, may hold benefits.&nbsp;“I’ve heard great things to do with medical, and I’ve heard bad things having to do with just about everything else but medical,” he said.Reclassification of marijuana from a Schedule I drug to a Schedule III drug would ease restrictions, allow tax breaks, and expand medical research.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-declares-liberation-day-in-dc-pushes-takeover-of-city-police/chrHGOoRdee">Trump Declares ‘Liberation Day’ in DC, Pushes Takeover Of City Police</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump answers questions during a press conference in the James S. Brady Press Briefing Room of the White House August 11, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Trump Confirms Marijuana Reclassification Decision To Be Made In ‘Next Few Weeks’ 

The President noted that there’s a difference of opinion on the benefits of marijuana, but added that he’s heard “great things” with respect to medical marijuana, specifically.

Equity

Stryker (SYK) Q2 Earnings and Revenues Beat Estimates

Stryker (SYK) delivered earnings and revenue surprises of +2.29% and +1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Tops Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates

Ayr Wellness, Inc. engages in the cultivation and manufacture of cannabis products. It produces cannabis packaged goods under the CannaPunch, Dutch Girl and Nordic Goddess brands. The company was founded on July 31, 2017 and is headquartered in Miami, FL.

Ayr Wellness Inc. - Ordinary Shares (Sub, Restricted, Ltd Voting)

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

AYRWF
Ayr Wellness Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AYRWF News

AYRWFAyr Wellness Inc